+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Accelerate Diagnostics Inc (AXDX) - Product Pipeline Analysis, 2021 Update

  • ID: 5367400
  • Company Profile
  • June 2021
  • 37 pages
  • GlobalData

FEATURED COMPANIES

  • Becton Dickinson and Co
  • bioMerieux SA
  • Bruker Corp
  • Danaher Corp
  • Luminex Corp
  • T2 Biosystems Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that carries out the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit which provides ID and AST results for patients with bacteremia or fungemia. The company has a manufacturing facility in Tucson Arizona. It sells products directly and also through a network of third-party distributors to hospital microbiology laboratories in domestic and foreign countries. Accelerate is headquartered in Tucson, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Accelerate Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Becton Dickinson and Co
  • bioMerieux SA
  • Bruker Corp
  • Danaher Corp
  • Luminex Corp
  • T2 Biosystems Inc
Accelerate Diagnostics Inc Company Overview
  • Accelerate Diagnostics Inc Company Snapshot
  • Accelerate Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Accelerate Diagnostics Inc - Pipeline Analysis Overview
  • Business Description
  • Accelerate Diagnostics Inc - Key Facts
  • Accelerate Diagnostics Inc - Major Products and Services
  • Accelerate Diagnostics Inc Pipeline Products by Development Stage
  • Accelerate Diagnostics Inc Ongoing Clinical Trials by Trial Status
Accelerate Diagnostics Inc Pipeline Products Overview
  • Accelerate ID/AST System - Secondary Infections
  • Accelerate ID/AST System - Secondary Infections Product Overview
  • Accelerate ID/AST System - Wound Infections
  • Accelerate ID/AST System - Wound Infections Product Overview
  • Accelerate ID/AST System - Carbepenem Resistance Testing
  • Accelerate ID/AST System - Carbepenem Resistance Testing Product Overview
  • Accelerate ID/AST System - Carbepenem Resistance Testing Clinical Trial
  • Accelerate Pheno System - Intra-Abdominal Infections Assay
  • Accelerate Pheno System - Intra-Abdominal Infections Assay Product Overview
  • Accelerate Pheno System - Urinary Tract Infections Assay
  • Accelerate Pheno System - Urinary Tract Infections Assay Product Overview
  • Accelerate PhenoPrep System
  • Accelerate PhenoPrep System Product Overview
  • Accelerate PhenoTest svBP (Bacterial Pneumonia) Kit
  • Accelerate PhenoTest svBP (Bacterial Pneumonia) Kit Product Overview
  • BAC-Xtrax System
  • BAC-Xtrax System Product Overview
  • Diagnostic Test - Antibiotic-Resistant Biothreat Agents
  • Diagnostic Test - Antibiotic-Resistant Biothreat Agents Product Overview
  • Lower Respiratory Kit
  • Lower Respiratory Kit Product Overview
  • Pheno 2.0 System
  • Pheno 2.0 System Product Overview
Accelerate Diagnostics Inc - Key Competitors

Accelerate Diagnostics Inc - Key Employees
  • Accelerate Diagnostics Inc - Key Employee Biographies
Accelerate Diagnostics Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Accelerate Diagnostics Inc, Recent Developments
  • May 19, 2021: Accelerate Diagnostics to Participate in William Blair 41st Annual Growth Stock Conference on June 3, 2021
  • May 05, 2021: Accelerate Diagnostics to Host Call to Review First Quarter 2021 Results
  • Feb 01, 2021: Accelerate Diagnostics schedules call to review 2020 fourth quarter and full year results
  • Jul 16, 2020: Accelerate Diagnostics Schedules Call to Review Second Quarter 2020 Results
  • May 07, 2020: Accelerate Diagnostics Announces Preliminary First Quarter Financial Results and Provides COVID-19 Business Updates; Schedules First Quarter 2020 Financial Results Conference Call for May 7, 2020
  • Feb 18, 2020: Accelerate Diagnostics schedules call to review 2019 fourth quarter and full-year results
  • Jan 13, 2020: Accelerate Diagnostics announces preliminary fourth quarter and full-year 2019 financial results
  • Dec 04, 2019: Accelerate Diagnostics announces executive transition: Lawrence Mehren to retire as Chief Executive Officer; Jack Phillips appointed as Successor
  • Nov 07, 2019: Accelerate diagnostics reports third quarter 2019 financial results
  • Nov 04, 2019: Accelerate Diagnostics appoints Roland Diggelmann to its board of directors
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Accelerate Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Accelerate Diagnostics Inc Pipeline Products by Equipment Type
  • Accelerate Diagnostics Inc Pipeline Products by Indication
  • Accelerate Diagnostics Inc Ongoing Clinical Trials by Trial Status
  • Accelerate Diagnostics Inc, Key Facts
  • Accelerate Diagnostics Inc, Major Products and Services
  • Accelerate Diagnostics Inc Number of Pipeline Products by Development Stage
  • Accelerate Diagnostics Inc Pipeline Products Summary by Development Stage
  • Accelerate Diagnostics Inc Ongoing Clinical Trials by Trial Status
  • Accelerate Diagnostics Inc Ongoing Clinical Trials Summary
  • Accelerate ID/AST System - Secondary Infections - Product Status
  • Accelerate ID/AST System - Secondary Infections - Product Description
  • Accelerate ID/AST System - Wound Infections - Product Status
  • Accelerate ID/AST System - Wound Infections - Product Description
  • Accelerate ID/AST System - Carbepenem Resistance Testing - Product Status
  • Accelerate ID/AST System - Carbepenem Resistance Testing - Product Description
  • Accelerate ID/AST System - Carbepenem Resistance Testing - Ultra Rapid Culture Independent Detection of High-priority Carbapenem Resistant Enterobacteriaceae Directly from Blood
  • Accelerate Pheno System - Intra-Abdominal Infections Assay - Product Status
  • Accelerate Pheno System - Intra-Abdominal Infections Assay - Product Description
  • Accelerate Pheno System - Urinary Tract Infections Assay - Product Status
  • Accelerate Pheno System - Urinary Tract Infections Assay - Product Description
  • Accelerate PhenoPrep System - Product Status
  • Accelerate PhenoPrep System - Product Description
  • Accelerate PhenoTest svBP (Bacterial Pneumonia) Kit - Product Status
  • Accelerate PhenoTest svBP (Bacterial Pneumonia) Kit - Product Description
  • BAC-Xtrax System - Product Status
  • BAC-Xtrax System - Product Description
  • Diagnostic Test - Antibiotic-Resistant Biothreat Agents - Product Status
  • Diagnostic Test - Antibiotic-Resistant Biothreat Agents - Product Description
  • Lower Respiratory Kit - Product Status
  • Lower Respiratory Kit - Product Description
  • Pheno 2.0 System - Product Status
  • Pheno 2.0 System - Product Description
Accelerate Diagnostics Inc, Key Employees
  • Accelerate Diagnostics Inc, Key Employee Biographies
  • Accelerate Diagnostics Inc, Subsidiaries
  • Glossary
List of Figures
  • Accelerate Diagnostics Inc Pipeline Products by Equipment Type
  • Accelerate Diagnostics Inc Pipeline Products by Development Stage
  • Accelerate Diagnostics Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Danaher Corp
  • Luminex Corp
  • Bruker Corp
  • bioMerieux SA
  • Becton Dickinson and Co
  • T2 Biosystems Inc
Note: Product cover images may vary from those shown
Adroll
adroll